BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 12836337)

  • 1. Characterization of pro-apoptotic gene Bak using hammerhead ribozymes.
    Suyama E; Kawasaki H; Taira K
    Nucleic Acids Res Suppl; 2001; (1):207-8. PubMed ID: 12836337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a caspase 3-independent role of pro-apoptotic factor Bak in TNF-alpha-induced apoptosis.
    Suyama E; Kawasaki H; Taira K
    FEBS Lett; 2002 Sep; 528(1-3):63-9. PubMed ID: 12297281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a hammerhead ribozyme against bcl-2. I. Preliminary evaluation of a potential gene therapeutic agent for hormone-refractory human prostate cancer.
    Dorai T; Olsson CA; Katz AE; Buttyan R
    Prostate; 1997 Sep; 32(4):246-58. PubMed ID: 9288183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of apoptosis by the Bcl-2 homologue Bak.
    Chittenden T; Harrington EA; O'Connor R; Flemington C; Lutz RJ; Evan GI; Guild BC
    Nature; 1995 Apr; 374(6524):733-6. PubMed ID: 7715730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hammerhead ribozymes targeted to the FBN1 mRNA can discriminate a single base mismatch between ribozyme and target.
    Phylactou LA; Tsipouras P; Kilpatrick MW
    Biochem Biophys Res Commun; 1998 Aug; 249(3):804-10. PubMed ID: 9731217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulation of bcl-2 expression in lymphoma cells by bcl-2 ARE-targeted modified, synthetic ribozyme.
    Luzi E; Papucci L; Schiavone N; Donnini M; Lapucci A; Tempestini A; Witort E; Nicolin A; Capaccioli S
    Cancer Gene Ther; 2003 Mar; 10(3):201-8. PubMed ID: 12637941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional analysis of the pro-apoptotic factor Bax using hammerhead ribozymes.
    Takeda H; Kawasaki H; Taira K
    Nucleic Acids Symp Ser; 2000; (44):169-70. PubMed ID: 12903322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of apoptosis by the widely distributed Bcl-2 homologue Bak.
    Kiefer MC; Brauer MJ; Powers VC; Wu JJ; Umansky SR; Tomei LD; Barr PJ
    Nature; 1995 Apr; 374(6524):736-9. PubMed ID: 7715731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Taxol and estramustine-induced modulation of human prostate cancer cell apoptosis via alteration in bcl-xL and bak expression.
    Liu QY; Stein CA
    Clin Cancer Res; 1997 Nov; 3(11):2039-46. PubMed ID: 9815595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different expression patterns of Bcl-2 family genes in breast cancer by estrogen receptor status with special reference to pro-apoptotic Bak gene.
    Eguchi H; Suga K; Saji H; Toi M; Nakachi K; Hayashi SI
    Cell Death Differ; 2000 May; 7(5):439-46. PubMed ID: 10800077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In non-transformed cells Bak activates upon loss of anti-apoptotic Bcl-XL and Mcl-1 but in the absence of active BH3-only proteins.
    Senft D; Weber A; Saathoff F; Berking C; Heppt MV; Kammerbauer C; Rothenfusser S; Kellner S; Kurgyis Z; Besch R; Häcker G
    Cell Death Dis; 2015 Nov; 6(11):e1996. PubMed ID: 26610208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of apoptosis in prostate carcinoma cells by BH3 peptides which inhibit Bak/Bcl-2 interactions.
    Finnegan NM; Curtin JF; Prevost G; Morgan B; Cotter TG
    Br J Cancer; 2001 Jul; 85(1):115-21. PubMed ID: 11437412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An interconnected hierarchical model of cell death regulation by the BCL-2 family.
    Chen HC; Kanai M; Inoue-Yamauchi A; Tu HC; Huang Y; Ren D; Kim H; Takeda S; Reyna DE; Chan PM; Ganesan YT; Liao CP; Gavathiotis E; Hsieh JJ; Cheng EH
    Nat Cell Biol; 2015 Oct; 17(10):1270-81. PubMed ID: 26344567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of action of hammerhead ribozymes and their applications in vivo: rapid identification of functional genes in the post-genome era by novel hybrid ribozyme libraries.
    Takagi Y; Suyama E; Kawasaki H; Miyagishi M; Taira K
    Biochem Soc Trans; 2002 Nov; 30(Pt 6):1145-9. PubMed ID: 12440992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A method for prediction of accessible sites on an mRNA sequence for target selection of hammerhead ribozymes.
    Mercatanti A; Rainaldi G; Mariani L; Marangoni R; Citti L
    J Comput Biol; 2002; 9(4):641-53. PubMed ID: 12323098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bax- and Bak-induced cell death in the fission yeast Schizosaccharomyces pombe.
    Jürgensmeier JM; Krajewski S; Armstrong RC; Wilson GM; Oltersdorf T; Fritz LC; Reed JC; Ottilie S
    Mol Biol Cell; 1997 Feb; 8(2):325-39. PubMed ID: 9190211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the anti-apoptotic mechanism of Bcl-B.
    Zhai D; Ke N; Zhang H; Ladror U; Joseph M; Eichinger A; Godzik A; Ng SC; Reed JC
    Biochem J; 2003 Nov; 376(Pt 1):229-36. PubMed ID: 12921534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. M. leprae inhibits apoptosis in THP-1 cells by downregulation of Bad and Bak and upregulation of Mcl-1 gene expression.
    Hasan Z; Ashraf M; Tayyebi A; Hussain R
    BMC Microbiol; 2006 Sep; 6():78. PubMed ID: 16978419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of proapoptotic molecules Bax and Bak in tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced mitochondrial disruption and apoptosis: differential regulation of cytochrome c and Smac/DIABLO release.
    Kandasamy K; Srinivasula SM; Alnemri ES; Thompson CB; Korsmeyer SJ; Bryant JL; Srivastava RK
    Cancer Res; 2003 Apr; 63(7):1712-21. PubMed ID: 12670926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NBK/BIK antagonizes MCL-1 and BCL-XL and activates BAK-mediated apoptosis in response to protein synthesis inhibition.
    Shimazu T; Degenhardt K; Nur-E-Kamal A; Zhang J; Yoshida T; Zhang Y; Mathew R; White E; Inouye M
    Genes Dev; 2007 Apr; 21(8):929-41. PubMed ID: 17403773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.